Latest filing published 29 May 2012 for ANAVEX LIFE SCIENCES CORP., €6,382.
Insider track record
No signal scores available.
Harvey Lalach: trading record in brief
This profile gathers the share dealings of Harvey Lalach in Anavex Life Sciences Corp. We count 11 filings; the first trade dates from 12 June 2006 and the latest from 29 May 2012.
Every open-market trade on record is a sale: 10 sales worth €83k. 2012 to date brings no purchases and 2 sales.
Most recently, on 29 May 2012, the filings show an open-market sale worth €6,382 in Anavex Life Sciences Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Harvey Lalach
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.80common stockSEC:0001140361-12-027748:0
- 8,572 shares@ US$1.05common stockSEC:0001140361-12-027748:1
- 2,100 shares@ US$3.05common stockSEC:0001140361-11-033273:0
- 3,200 shares@ US$2.90common stockSEC:0001140361-11-033273:1
- 3,000 shares@ US$2.84common stockSEC:0001140361-11-033273:2
- 3,000 shares@ US$2.81common stockSEC:0001140361-11-033273:3
- 10,000 shares@ US$2.75common stockSEC:0001140361-11-022491:0
- 5,500 shares@ US$3.68common stockSEC:0001140361-11-016489:0
- 3,000 shares@ US$3.75common stockSEC:0001140361-11-011700:0
- 1,628 shares@ US$3.74common stockSEC:0001140361-11-011700:1
- 500,000 shares0CommonSEC:0001360545-06-000003:0
11 of 11 declarations